Are you ready to change your approach to Alzheimer's?
Get your copy of Breaking Alzheimer's today.
Breaking Alzheimer's
A 15 year crusade to expose the cause and deliver the cure
– Dayan Goodenowe, PHD
Breaking Alzheimer’s by Dayan Goodenowe, PhD, explores the biochemical roots of Alzheimer’s disease, focusing on the link between low plasmalogen levels and cognitive decline. Drawing on over 20 years of research in neurological biochemistry and lipid science, Dr. Goodenowe explains complex biological mechanisms in accessible terms, from how plasmalogens function in the brain to why their depletion matters for neurodegeneration.
The book is aimed at curious readers, science-minded individuals, and practitioners looking for a rigorous, research-grounded examination of Alzheimer’s biology.
About the Author
Dr. Dayan Goodenowe, PhD, is a neuroscientist and biochemical researcher known for his work on lipid metabolism and neurological processes. His research explores the foundational biochemistry of cognition and biological resilience.
What You’ll Learn
- The role of plasmalogens in brain health
- How biochemical mechanisms relate to cognitive decline
- The progression of research over 15+ years
- Key scientific principles explained for general audiences
Reader Audience
Targeted toward:
science-minded readers
healthcare professionals and students
individuals seeking evidence-based insights on neurobiology
A paradigm-altering view of Alzheimer's.
Dale Bredesen, MD
Author of The New York Times Bestseller The End of Alzheimer’s
Dr. Goodenowe & Breaking Alzheimer's
Dr. Goodenowe was the first to identify an association between low blood plasmalogen levels and increased Alzheimer’s risk , a relationship that, based on his research, may be comparable to established risk factors like age and the APOE ε4 genotype. He followed this discovery with extensive research to better understand the role of plasmalogens in cognitive decline.
Because dietary plasmalogens break down in the digestive tract before they can be effectively absorbed, Dr. Goodenowe designed and patented targeted plasmalogen precursors, stable, bioavailable compounds that can be taken orally and absorbed by cells throughout the body, including the brain, to support the production and maintenance of healthy plasmalogen levels.
What Readers Are Saying
“A brilliant and ground-breaking text on the science and clinical application of plasmalogens for the therapeutic amelioration of Alzheimer’s Dementia. I have had the good fortune of observing firsthand the significant, clinical benefits in my patients with neurodegenerative disorders for whom I’ve prescribed plasmalogen therapy.”
Mitchel Fleisher M.D., D.Ht., D.A.B.F.M., Dc.A.B.C.T.
Medical Director, Center for Integrative & Regenerative Medicine
“Dr. Goodenowe has not only identified a biomarker—plasmalogen—that is strongly correlated with dementia, but he has also discovered a way to track and improve that marker allowing ApoE4 carriers, at the highest genetic risk for Alzheimer’s, to potentially avoid disease onset. Indeed, many of our members have had a noticeable improvement after addressing low levels.”
Julie Gregory
Founder & President of ApoE4.Info
“A bold and promising approach. Dr. Goodenowe has performed groundbreaking and compelling research which is detailed in the book so that afflicted patients and health professionals will become aware of a discovery which may very well change our approach to Alzheimer’s. We have been deploying plasmalogen precursors at the Regenesis Project and have found that within the timeframe of a few weeks, people become more alert and cognizant.”
Sheldon Jordan, MD, FAAN, DABPN, DABCN
Medical Director, the Regenesis Project
“I strongly recommend this book which I hope will be as transformative for you as it has been for me. It is easy to read and understand and will impact your everyday decision making.”
Bijan Pourat MD ACC FRCP(C)
“Dayan Goodenowe has drilled down to the very core of what makes us tick. His patient 25 year journey of research and invention has unpacked unique and marvelous understanding into how our metabolic engine works. We have a whole new field of medicine opening up called “metabolic medicine” and it runs right through Dr. Goodenowe’s inventions. Like tuning your carburetor and timing your engine, we can now heal your mitochondria and make your peroxisomes whistle with the careful measurement and replacement of plasmalogens. The implications of his inventions can’t be overstated. This is the end of Alzheimer’s, Parkinson’s, cancer….and who knows what lies ahead in the paradigm shift to true wellness with the absence of disease.”
John E. Whitcomb, MD
Brookfield Longevity Medical Clinic